Accel-Amplicon® 57G Pan-Cancer Profiling Panel by Integrated DNA Technologies Inc.

Manufacturer Integrated DNA Technologies Inc.  |   Model: AP-PC8048
Customizable Targeting of Key Oncology Variants


Accel-Amplicon® 57G Pan-Cancer Profiling Panel by Integrated DNA Technologies Inc. product image
Accel-Amplicon® 57G Pan-Cancer Profiling Panel
Buy Now

Place your order directly with the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The Accel-Amplicon® 57G Pan-Cancer Profiling Panel is a great starting point for any cancer sequencing project. The 57G Pan-Cancer Panel builds off our previous 56G Oncology Panel, and offers much more. At its core, the panel offers comprehensive and hotspot coverage of 57 clinically-relevant oncology-related genes implicated in both solid tumors and hematological cancers. It is flexible too, allowing you to stack modules of content to achieve your most optimal design. Either choose from our pre-validated content, such as BRCA1, BRCA2, EGFR, etc. or add your own targets. We’ll work alongside you to design your assay and then we will optimize and wet-bench validate its performance before shipping to you.

Key features include:

  • Robust performance on cell-free DNA and FFPE samples starting with as little as 10 ng input
  • Sensitive detection of rare variants down to 1% allele frequency
  • Easy, single-tube assay with sequence ready libraries in 2 hours
  • Compatible with all Illumina® sequencers

Product Overview

Accel-Amplicon® 57G Pan-Cancer Profiling Panel by Integrated DNA Technologies Inc. product image

Accel-Amplicon® 57G Pan-Cancer Profiling Panel

Manufacturer Integrated DNA Technologies Inc.

Be the first to review this product